e-learning
resources
Virtual 2021
06.09.2021
Health effects of tobacco and medical professionals
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of Cardiovascular Disease on dyspnea and lung function in a population of Tunisian smokers without airflow limitation
K. Kchaou (Ariana, Tunisia), A. Ben Ayed (Ariana, Tunisia), A. Chaker (Ariana, Tunisia), S. Khaldi (Ariana, Tunisia), S. Mokaddem (Ariana, Tunisia), S. Jameleddine (Ariana, Tunisia)
Source:
Virtual Congress 2021 – Health effects of tobacco and medical professionals
Session:
Health effects of tobacco and medical professionals
Session type:
E-poster
Number:
2444
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kchaou (Ariana, Tunisia), A. Ben Ayed (Ariana, Tunisia), A. Chaker (Ariana, Tunisia), S. Khaldi (Ariana, Tunisia), S. Mokaddem (Ariana, Tunisia), S. Jameleddine (Ariana, Tunisia). Impact of Cardiovascular Disease on dyspnea and lung function in a population of Tunisian smokers without airflow limitation. 2444
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
The importance of dyspnea and airflow limitation for anxiety and depression in COPD
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013
Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Obstructive sleep apnea accelerates decline in FEV1 in asthmatic patients
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Association between airflow limitation severity and comorbidities in Japanese men
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020
Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Determinants of dyspnea in COPD patients: the French PALOMB cohort
Source: International Congress 2018 – COPD around the world
Year: 2018
Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Cardiovascular limitation to exercise in COPD patients
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010
Determinants for the reversibility of airflow limitation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 289s
Year: 2005
Airflow limitation and airway inflammation of asthmatic adolescents in remission
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Ventilation inhomogeneity in children with severe asthma and normal spirometry indicates residual airways disease
Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children
Year: 2013
Comorbidities impair physical activity in COPD irrespective of airflow limitation
Source: International Congress 2014 – Comorbidities
Year: 2014
Impacts of bronchiectasis in asthma patients with airflow limitation
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Impact of airflow obstruction severity on the course of COPD during follow-up
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Cardiac structure and function at baseline in the DEFLATA study: The impact of lung hyperinflation and its relationship with the GOLD classification
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept